Geode Capital Management’s Pyxis Oncology PYXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Sell |
510,963
-598,135
| -54% | -$658K | ﹤0.01% | 3516 |
|
|
2025
Q1 | $1.09M | Buy |
1,109,098
+26,649
| +2% | +$26.1K | ﹤0.01% | 3279 |
|
|
2024
Q4 | $1.69M | Sell |
1,082,449
-2,278
| -0.2% | -$3.55K | ﹤0.01% | 3194 |
|
|
2024
Q3 | $3.98M | Buy |
1,084,727
+57,016
| +6% | +$209K | ﹤0.01% | 2883 |
|
|
2024
Q2 | $3.4M | Buy |
1,027,711
+687,590
| +202% | +$2.28M | ﹤0.01% | 2927 |
|
|
2024
Q1 | $1.45M | Buy |
340,121
+31,880
| +10% | +$136K | ﹤0.01% | 3234 |
|
|
2023
Q4 | $555K | Buy |
308,241
+19,942
| +7% | +$35.9K | ﹤0.01% | 3567 |
|
|
2023
Q3 | $574K | Buy |
288,299
+45,512
| +19% | +$90.6K | ﹤0.01% | 3546 |
|
|
2023
Q2 | $622K | Buy |
242,787
+3,436
| +1% | +$8.8K | ﹤0.01% | 3559 |
|
|
2023
Q1 | $960K | Buy |
239,351
+35,417
| +17% | +$142K | ﹤0.01% | 3367 |
|
|
2022
Q4 | $273K | Buy |
203,934
+15,113
| +8% | +$20.2K | ﹤0.01% | 3935 |
|
|
2022
Q3 | $371K | Buy |
188,821
+78,974
| +72% | +$155K | ﹤0.01% | 3887 |
|
|
2022
Q2 | $261K | Sell |
109,847
-84,730
| -44% | -$201K | ﹤0.01% | 4109 |
|
|
2022
Q1 | $786K | Buy |
194,577
+13,105
| +7% | +$52.9K | ﹤0.01% | 3720 |
|
|
2021
Q4 | $1.99M | Buy |
+181,472
| New | +$1.99M | ﹤0.01% | 3361 |
|